Loading
Loading
Organ & Bioregulator Research · 20mg
Janoshik-tested · 10 vials per kit
Bronchogen is a synthetic tetrapeptide bioregulator studied in preclinical research for its effects on respiratory system tissues. Research has examined its potential to alleviate inflammation, promote bronchial tissue repair and regeneration, modulate immune responses, and enhance mucociliary clearance. Studies have explored applications in chronic bronchitis, asthma, and COPD models.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Chemical Properties
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Bronchogen
Bronchogen is a synthetic tetrapeptide developed as a bronchial bioregulator in the Khavinson research programme. It is studied for regulatory effects on bronchial smooth muscle, mucosal cells, and inflammatory mediator production in respiratory tissue.
Like other Khavinson bioregulators, Bronchogen is proposed to interact with promoter regions of target cell chromatin, regulating gene expression in bronchial and respiratory mucosal cells. Effects on mucus secretion, bronchial smooth muscle tone, and inflammatory mediator profiles have been described in animal models.
Preclinical research describes benefits in chronic bronchitis models, asthma models, and age-related pulmonary decline in rodents. Bronchogen is often included alongside Chonluten in organ-specific bioregulator protocols targeting respiratory longevity.
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
